| Darren P Bryant, MD | |
|
1 Hospital Dr, Suite 4200, Asheville, NC 28801-4550 | |
| (828) 213-1995 | |
| Not Available |
| Full Name | Darren P Bryant |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1 Hospital Dr, Asheville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003873993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | MD067156L (Pennsylvania) | Secondary |
| 208600000X | Surgery | 2010-01514 (North Carolina) | Primary |
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452482 PECOS PAC ID: 0648189969 Enrollment ID: O20040309000878 |
News Archive
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Small U.S.-based companies developing countermeasures to protect healthy tissue from the effects of radiation exposures may be eligible for a unique funding opportunity offered through the National Space Biomedical Research Institute. NSBRI's Industry Forum is soliciting applications for its Space Medical and Related Technologies Commercialization Assistance Program (SMARTCAP).
U.N. Secretary-General Ban Ki-moon on Monday "strongly condemned the killing in north-eastern Nigeria of three doctors from the Democratic People's Republic of Korea, calling the attack and other recent incidents of violence against health workers 'unacceptable,'" the U.N. News Centre reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.
› Verified 6 days ago
| Entity Name | Blue Ridge Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447261698 PECOS PAC ID: 0648181966 Enrollment ID: O20040729001574 |
News Archive
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Small U.S.-based companies developing countermeasures to protect healthy tissue from the effects of radiation exposures may be eligible for a unique funding opportunity offered through the National Space Biomedical Research Institute. NSBRI's Industry Forum is soliciting applications for its Space Medical and Related Technologies Commercialization Assistance Program (SMARTCAP).
U.N. Secretary-General Ban Ki-moon on Monday "strongly condemned the killing in north-eastern Nigeria of three doctors from the Democratic People's Republic of Korea, calling the attack and other recent incidents of violence against health workers 'unacceptable,'" the U.N. News Centre reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.
› Verified 6 days ago
| Entity Name | Mission Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114150190 PECOS PAC ID: 0749326106 Enrollment ID: O20100313000054 |
News Archive
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Small U.S.-based companies developing countermeasures to protect healthy tissue from the effects of radiation exposures may be eligible for a unique funding opportunity offered through the National Space Biomedical Research Institute. NSBRI's Industry Forum is soliciting applications for its Space Medical and Related Technologies Commercialization Assistance Program (SMARTCAP).
U.N. Secretary-General Ban Ki-moon on Monday "strongly condemned the killing in north-eastern Nigeria of three doctors from the Democratic People's Republic of Korea, calling the attack and other recent incidents of violence against health workers 'unacceptable,'" the U.N. News Centre reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.
› Verified 6 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532021 PECOS PAC ID: 0648189969 Enrollment ID: O20120316000506 |
News Archive
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Small U.S.-based companies developing countermeasures to protect healthy tissue from the effects of radiation exposures may be eligible for a unique funding opportunity offered through the National Space Biomedical Research Institute. NSBRI's Industry Forum is soliciting applications for its Space Medical and Related Technologies Commercialization Assistance Program (SMARTCAP).
U.N. Secretary-General Ban Ki-moon on Monday "strongly condemned the killing in north-eastern Nigeria of three doctors from the Democratic People's Republic of Korea, calling the attack and other recent incidents of violence against health workers 'unacceptable,'" the U.N. News Centre reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darren P Bryant, MD Po Box 602373, Charlotte, NC 28260-2373 Ph: (828) 250-2833 | Darren P Bryant, MD 1 Hospital Dr, Suite 4200, Asheville, NC 28801-4550 Ph: (828) 213-1995 |
News Archive
Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up, according to new research published today (Wednesday) in the European Heart Journal.
Small U.S.-based companies developing countermeasures to protect healthy tissue from the effects of radiation exposures may be eligible for a unique funding opportunity offered through the National Space Biomedical Research Institute. NSBRI's Industry Forum is soliciting applications for its Space Medical and Related Technologies Commercialization Assistance Program (SMARTCAP).
U.N. Secretary-General Ban Ki-moon on Monday "strongly condemned the killing in north-eastern Nigeria of three doctors from the Democratic People's Republic of Korea, calling the attack and other recent incidents of violence against health workers 'unacceptable,'" the U.N. News Centre reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.
› Verified 6 days ago
William Alan Bradshaw, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 14 Medical Park Dr, Asheville, NC 28803 Phone: 828-252-3366 Fax: 828-258-0891 | |
John P Henretta, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 Asheland Ave, Asheville, NC 28801 Phone: 828-213-9090 Fax: 828-213-9091 | |
William Shillinglaw, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1995 Fax: 828-213-1992 | |
Dr. Emma Goldsmith Rooney, MD Surgery Medicare: Medicare Enrolled Practice Location: 222 Asheland Ave, Asheville, NC 28801 Phone: 828-213-9090 | |
Michael J Schurr, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Suite 4200, Asheville, NC 28801 Phone: 828-213-1994 | |
Dr. Amir Ali Neshat, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 28 Ashley Rd, Asheville, NC 28805 Phone: 828-298-2014 |